Discover the facial procedures patients are requesting most, from deep plane facelifts to fat grafting, with insights from Dr ...

The epidermal growth factor receptor (EGFR) is one of the most extensively studied targets in cancer therapy, yet its complex regulatory mechanisms remain partially understood. While traditional ...

RBI has proposed a draft Model Risk Management Framework requiring banks and financial institutions to set up board-approved ...

Global medical aesthetics leader Cynosure Lutronic presented its latest non-invasive innovations at IMCAS Asia 2026 in ...

A non-governmental organisation, Thrivescape Initiative, has emphasised the need for a more proactive, coordinated, and ...

The European Council’s latest mandate pairs dialogue with prospective new trade defense tools, institutionalizing an approach ...

Treasury Secretary Scott Bessent defended the Trump administration's use of tariffs as a strategic tool that unlocked trade ...

Investors are increasingly weighing whether current weakness presents a buying opportunity or signals the potential for ...

The one-year correlation between the S&P Equal Weight Index and S&P 500 has dropped to a record low of 79%, revealing extreme ...

The $648 billion care economy has been systematically underpriced by venture capital. Kalos Ventures' Ashley Bittner bet on ...

Campbell's margins are worsening and asset efficiency lags peers—raising dividend cut risk. Fnid out why CPB stock is a Sell.

Recruiter outreach has slowed, hiring processes stall, and qualified executives are being overlooked. Here’s what leaders ...